Helicos Sells Certain MDx IP to Sequenom for $1.3M, Warns of Potential Bankruptcy | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences has sold certain patent applications covering molecular diagnostic applications of its technology to Sequenom for $1.3 million, the firm disclosed in a filing with the US Securities and Exchange Commission yesterday after the close of the market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.